Regulation of nitric oxide synthesis in the liver

Journal of Applied Toxicology

Volumn 20, Issue 3, 2000, Pages 189-195

  Muriel, Pablo ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

Arginine; Cytokines; Liver; LPS; Nitric oxide; NOS

Indexed keywords

ARGININE; BACTERIUM LIPOPOLYSACCHARIDE; CITRULLINE; CYTOKINE; FREE RADICAL; GUANIDINE DERIVATIVE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OXYGEN;

ARTICLE; BIOGENESIS; CATALYSIS; ENDOTHELIUM; ENZYME ACTIVITY; HUMAN; KUPFFER CELL; LIVER; LIVER CELL; NERVE CELL; PRIORITY JOURNAL; REGULATORY MECHANISM; STELLATE CELL; SYNTHESIS;

ANIMALS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; ISOENZYMES; LIVER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

BACTERIA (MICROORGANISMS);

EID: 0034092860     PISSN: 0260437X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1263(200005/06)20:3<189::AID-JAT632>3.0.CO;2-8     Document Type: Article

References (80)

1. H. H. Kitade, K. Sakitani, K. Inove, N. Masu y Kawada, Y. Hiramatsu, Y. Kamiyama. T. Okumura and S. Ito, Interleucin 1B markedly stimulates nitric oxide formation in the absence of other cytokines or lipopolysaccharide in primary cultured rat hepatocytes but not in kuppfer cells. Hepatology 23, 797-802 (1996).
2. C. A. Salkowski, G. Detore, R. McNally, N. Van Rooijen and S. N. Vogel, Regulation of inducible nitric oxide synthase messenger RNA expression and nitric oxide production by lipopolysaccharide in vivo. J. Immunol. 158, 905-912 (1997).
3. U. Forstermann, J. S. Pollock, H. H. H. W. Schmidt, M. Heller and F. Murad, Calmodulin-dependent endothelium-derived relaxing factor/nitric oxide synthase activity is present in the particulate and cytosolic fractions of bovine aortic endothelial cells. Proc. Natl. Acad. Sci. USA 88, 1788-1792 (1991).
4. A. M. Leone, R. M. J. Palmer, R. G. Knowles, P. L. Francis, D. S. Asthon and S. Moncada, Constitutive and inducible nitric oxide syntheases incorporate molecular oxygen into both nitric oxide and citrulline. J. Biol. Chem. 266, 23790-23795 (1991).
5. S. Moncada, R. M. J. Palmer and E. A. Higgs. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43, 109-142 (1991).
6. T. Gotoh, T. Sonoki, A. Nagasaki, K. Terada, M. Takiguchi and M. Mori, Molecular cloning of cDNA for nonhepatic mitochondrial arginase (arginase II) and comparison of its induction with nitric oxide synthase in a murine macrophage-like cell line. FEBS Lett. 395, 119-122 (1996).
7. I. M. Abou-Soud and D. J. Stuehr. Nitric oxide synthases reveal a role for calmodulin in controlling electron transfer. Proc. Natl. Acad. Sci. USA 90, 10769-10772 (1993).
8. S. Moncada and A. Higgs, The L-arginine-nitric oxide pathway. N. Engl. J. Med. 329(27), 2002-2012 (1993).
9. G-nitro-L-arginine. Life Sci. 60(20), 1803-1809 (1997).
10. T. Sonoki, A. Nagasaki, T. Gotoh, M. Takeguchi, M. Takeyra, H. Matsuzaki and M. Mori. Conduction of nitric-oxide synthase and arginase I in cultured rat peritoneal macrophages and rat tissue in vivo by lipopolysaccharide. J. Biol. Chem. 272(6), 3689-3693 (1997).
11. R. McAllister, H. Parry, M. Kimoto, T. Ogawa, M. J. Russell, H. Hodson, G. J. Whitley and P. Vallance, Regulation of nitric oxide synthesis by dimethylarginine methylaminohydrolase. Br. J. Pharmacol. 119, 1533-1540 (1996).
12. R. J. Maliakkal, T. A. Kihas, V. K. Kanji, A. K. Markov and A. A. Mihas, Effects of frucotse-1, 6-diphosphate on the activity of rat liver nitric oxide synthase in vitro. Pharmacology 54, 43-48 (1997).
13. S. Moncada, R. M. J. Palmer and E. A. Higgs, Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43, 109-142 (1991).
14. I. M. Abu-Soud and D. J. Stuehr, Nitric oxide syntheses reveal a role for calmodulin in controlling electron transfer. Proc. Natl. Acad. Sci. USA 90, 10769-10772 (1993).
15. G. Schoedon, M. Schneemann, N. Blau, C. J. S. Edgell and A. Schaffner, Modulation of human endothelial cell tetrahydrobiopterin synthesis by activating and deactivating cytokines: new perspectives on endothelium-derived relaxing factor. Biochem. Biophys. Res. Commun. 196, 1343-1348 (1993).
16. E. R. Werner, G. Werner-Felmayer, D. Fuchs, A. Hause, G. Reibnegger, J. J. Yim and H. Wachter, Impact of tumour necrosis factor-α and interferon-γ on tetrahydrobiopterin synthesis in murine fibroblasts and macrophages. Biochem. J. 280, 709-714 (1981).
17. T. Fukushima and J. C. Nixon, Analysis of reduced forms of biopterin in biological tissues and fluids. Anal. Biochem. 102, 176-188 (1980).
18. R. G. Knowles, M. Merrett, M. Salter and S. Moncada, Differential induction of brain, lung, and liver nitric oxide synthase by endotoxin in the rat. Biochem. J. 270, 833-836 (1990).
19. D. J. Suehr, N. S. Kwon and C. F. Nathan, FAD and GSH participate in macrophage synthesis of nitric oxide. Biochem. Biophys. Res. Commun. 168, 558-565 (1990).
20. J. M. Griscavage, N. E. Rogers, M. P. Sherman and L. J. Ignarro, Inducible nitric oxide synthase from a rat alveolar macrophage cell line is inhibited by nitric oxide. J. Immunol. 151, 6329-6337 (1993).
21. J. A. Schmidt and E. Abdulla, Down-regulation of IL-1β biosynthesis by inducers of the heat shock response. J. Immunol. 141, 2027-2034 (1988).
22. S. Useno, A. Sano, K. Kotani, K. Kondoh, and T. Kakimoto, Distribution of free methylarginines in rat tissues and the bovine brain. J. Neurochem. 59, 2012-2016 (1992).
23. P. Vallance, A. Leone, A. Calver, J. Collier and S. Moncada, Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 339, 572-575 (1992).
24. W dimethylarginine by human endothelial cells. Endothelium 1, 137-140.
25. R. J. McAllister, S. A. Fickling, G. St J. Whitley and P. Balance, Metabolism of methylarginines by human vasculature: implications for the regulation of nitric oxide synthesis. Br. J. Pharmacol. 112, 43-48 (1994).
26. G dimethylaminohydrolases in the nitric oxige generating systems of rats using monoclonal antibody. Arch. Biochem. Biophys. 300, 657-662 (1993).
27. A. M. El-Badry, A. Otani, and T. E. Mansour, Studies on heart phosphofructokinase. Role of fructose-1, 6-diphosphate in enzyme activity. J. Biol. Chem. 248, 557-563 (1973).
28. J. P. Filkins and R. P. Cornell, Depression of hepatic gluconeogenesis and the hypoglycemia of endotoxic shock. Am. J. Physiol. 227, 778-781 (1974).
29. M. E. Kirtley, M. McKay, Fructose-1, 6-biphosphate, a regulator of metabolism. Mol. Cell Biochem. 18, 141-149 (1977).
30. A. K. Markov, N. Oglethorpe, J. Terry, J. B. Grogan and H. K. Hellems, Stimulating effect of fructose 1-6 diphosphate on the phagocytic function of rat RED and on human leukocyte carbohydrate metabolism. Am. J. Med. Sci. 290, 3-10 (1985).
31. J. Sun, L. A. Farias and A. K. Markov, Fructose-1, 6-diphosphate prevents intestinal ischemic reperfusion injury and death in rats. Gastroenterology 98, 117-126 (1990).
32. A. K. Markov, M. D. Turner, N. Oglethorpe, W. A. Neely and H. K. Hellems, Fructose-1,6-diphosphate: an agent for treatment of experimental endotoxin shock. Surgery 90, 482-488 (1981).
33. A. J. Markov, L. A. Farias, W. S. Bennett, C. Subramony and A. A. Mihas, Prevention of galactosamine-induced hepatotoxicity in rats with fructose-1,6-diphosphate. Pharmacology 43, 310-317 (1991).
34. T. Boyd, A. A. Mihas and A. K. Markov, Attenuation of carbon tetrachloride (CC14)-induced liver injury in rats with fructose 1-6 diphosphate (FDP) [Abstract]. Clin. Res. 35, 970A (1990).
35. D. L. Duval, D. R. Miller, J. Collier and R. E. Billings, Characterization of hepatic nitric oxide synthase: identification as the cytokine-inducible form primarily regulated by oxidants. Mol. Pharmacol. 50, 277-284 (1996).
36. D. J. Stuehr, N. S. Kwon and C. F. Nathan, FAD and GSH participate in macrophage synthesis of nitric oxide. Biophys. Res. Commun. 168, 558-565 (1990).
37. B. G. Harbrecht, M. Di Silvio, V. Chough, Y. M. Kim, R. L. Simmons and T. R. Billiard, Glutathione regulates nitric oxide synthase in cultured hepatocytes. Ann. Surg. 225(1), 76-87 (1997).
38. D. R. Miller, J. M. Collier and R. E. Billings, Protein tyrosine kinase activity regulates nitric oxide synthase induction in rat hepatocytes. Am. J. Physiol. (Gastrointest. Liver Physiol.) 35, G207-G214 (1997).
39. B. S. Lee, H. S. Kang, K. H. Pyun and I. Choi, Roles of tyrosine kinases in the regulation of nitric oxide synthesis in urine liver cells: modulation of NF-kB activity by tyrosine. Hepatology 25, 913-919 (1997).
40. 4 inhibit cytokine-stimulated nitric oxide synthase type 2 expression in isolated rat hepatocytes. Prostaglandins 52, 103-116 (1996).
41. K. Sakitani, H. Kitade, K. Inove, Y. Kamiyama, M. Nishizawa, T. Okumura and S. Ito. The anti-inflammatory drug sodium salicylate inhibits nitric oxide formation induced by interleukin-1β at a translational step, but not at a transcriptional step, in hepatocytes. Hepatology 25, 416-420 (1997).
42. kB and the induction and stability of nitric oxide synthase transcript in primary neonatal rat hepatocytes. FEBS Lett. 379, 279-285 (1996).
43. C. R. Roland, B. Naziruddin, T. Mohanakumar and M. W. Flye, Gadolinium chloride inhibits kupffer cell nitric oxide synthase (iNOS) induction. J. Leuk. Biol. 60, 487-492 (1996).
44. H. Kitade, K. Sakitani, K. Inove, Y. Masu, N. Kawada, Y. Hiramatsu, Y. Kamiyama, T. Okumura and S. Ito, Interleukin 1β markedly stimulates nitric oxide formation in the absence of other cytokines or lipopolysaccharide in primary cultured rat hepatocytes but not in kupffer cells. Hepatology 23, 797-802 (1996).
45. R. A. Schroeder, J. S. Gu and P. C. Kuo, Interleukin 1β-stimulated production of nitric oxide in rat hepatocytes in mediated through endogenous synthesis of interferon gamma. Hepatology 27, 711-719 (1998).
46. Y. C. Vodovotz, C. Bogdan, J. Paik, Q. W. Xie and C. Nathan, Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor. Br. J. Exp. Med. 178, 605 (1993).
47. C. A. Salkowski, G. Detore, R. McNally, N. Van Rooyen and S. N. Voge, Regulation of inducible nitric oxide synthase messenger RNA expression and nitric oxide production by lipopolysaccharide in vivo. J. Immunol. 138, 905-912 (1997).
48. F. Q. Cunha, S. Moncada and F. Y. Liew, Interleukin-10 (IL-10) inhibits the induction of nitric oxide synthase by interferon-γ in murine macrophages. Biochem. Biophys. Res. Commun. 182, 1155-1159 (1992).
49. J. Plfeilschifter, Platelet-derived growth factor inhibits cytokine induction of nitric oxide synthase in rat renal mesangial cells. Eur. J. Pharmacol. 208, 339-340 (1991).
50. A. Ding, C. F. Nathan, J. Graycar, R. Dernyck, D. J. Stuehr and S. Srimal, Macrophage deactivating factor and transforming growth factor-β1, β2, and -β3 inhibit induction of macrophage nitrogen oxide synthesis by IFN-γ. J. Immunol. 145, 940-944 (1990).
51. B. G. Harbrecht, E. M. Wirant, Y. M., Kim and T. R. Billiard, Glucagon inhibits hepatocyte nitric oxide synthesis. Arch. Surg. 131, 1266-1272 (1996).
52. F. S. Smith, E. D. Ceppi and M. A. Tetheradge, Inhibition of cytokine-induced inducible nitric oxide synthase expression by glucagon and cAMP in cultured hepatocytes. Biochem. J. 326, 187-192 (1997).
53. S. B. Mustafa and M. S. Olson, Expression of nitric-oxide synthase in rat kupffer cells is regulated by cAMP. J. Biol. Chem. 273(9), 5073-5080 (1993).
54. J. C. López-Talavera, G. Cadelina, J. Olchowski, W. Merrill and R. J. Groezman, Thaliclomide inhibits tumor necrosis factor α decreases nitric oxide synthesis, and ameliorates the hyperdynamic circulatory syndrome in portal-hypertensive rats. Hepatology 23, 1616-1621 (1996).
55. G. Werner-Felmayer, E. R. Werner, D. Fuchs, A. Hausen, G. Reibnegger, K. Schmidt, G. Weiss and H. Wachter, Pteridine biosynthesis in human endothelial cells. J. Biol. Chem. 268, 1842-1846 (1993).
56. M. E. De Vera, B. S. Taylor, Q. Wang, R. A. Shapiro, T. R. Billiar and D. A. Geller, Dexamethasone suppresses iNOS gene expression by upregulating l-k Bα and inhibiting NF-kB. Am. J. Physiol. Gastrointest. Liver Physiol. 36, G1290-G1296 (1997).
57. C. E. Bryant, M. Perretti and R. J. Flower, Suppression by dexamethasone of inducible nitric oxide synthase protein expression in vivo. A possible role for lipocortin 1. Biochem. Pharmacol. 55, 279-285 (1998).
58. M. E. de Vera, Y. M. Kim, H. R. Wong, Q. Wang, T. R. Billiar and D. A. Geller, Heat shock response inhibits cytokine-inducible nitric oxide synthase expression in rat hepatocytes. Hepatology 24, 1238-1245 (1996).
59. B. Gess, K. Schricker, M. Pfeifer and A. Kurtz, Acute hypoxia upregulates NOS gene expression in rats. Am. J. Physiol. (Regul. Integr. Comp. Physiol.) 273(42), R905-R910 (1997).
60. T. Gaillard, A. Mulsch, R. Busse, H. Klein and K. Decker, Regulation of nitric oxide production by stimulated rat kupffer cells. Pathobiology 59, 280-283 (1991).
61. B. G. Harbrecht, E. A. McClure, R. L. Simmons and T. R. Billiar, Prostanoids inhibit kupffer cell nitric oxide synthesis. J. Surg. Res. 58, 625-629 (1995).
62. 2 negatively modulates induction of nitric oxide synthase by interleukin 1. Proc. Natl. Acad. Sci. USA 91, 12168-12172 (1994).
63. S. Hortelo, A. M. Genaro and L. Bosca, Phorbol esters induce nitric oxide synthase activity in rat hepatocytes. J. Biol. Chem. 267, 24937-24940 (1992).
64. O. Letari, S. Nicosia, C. Chisvaroli, P. Vacher and W. Schlegel, Activation by bacterial lipopolysacharide causes changes in the cytosolic free calcium concentration in single peritoneal macrophages. J. Immunol. 147, 980-983 (1991).
65. M. W. Radomski, R. M. Palmer and S. Moncada, An L-arginine/nitric oxide pathway present in human platelets regulates aggregation. Proc. Natl. Acad. Sci. USA 87, 5193 (1990).
66. P. J. Shultz and L. Ray, Endogenously synthesized nitrix oxide prevents endotoxin-induced glomerular thrombosis. J. Clin. Invest. 90, 1718-1721 (1992).
67. J. A. Spitzer, Cytokine stimulation of nitric oxide formation and differential regulation in hepatocytes and nonparen-chymal cells of endotoxemic rats. Hepatology 19, 217-228 (1994).
68. R. D. Curran, T. R. Billiar, D. J. Stuehr, J. B. Ochoa, B. G. Harbrecht, S. G. Flint and R. L. Simmons, Multiple cytokines are required to induce hepatocytes nitric oxide production and inhibit total protein synthesis. Ann. Surg. 212, 462-471 (1990).
69. A. K. Nussler, M. Di Silvio, T. R. Billiar, R. A. Hoffman, D. A. Geller, R. Selby, J. Madariaga and R. L. Simmons, Stimulation of the nitric oxide synthase pathway in human hepatocytes and endotoxin. J. Exp. Med. 176, 261-264 (1992).
70. A. K. Nussler, D. A. Geller, M. A. Sweetland, M. Di Silvio, T. R. Billiar, J. B. Madariaga, R. L. Simmons et al., Induction of nitric oxide synthesis and its reactions in cultured human and rat hepatocytes stimulated with cytokines plus LPS. Biochem. Biophys. Res. Commun. 194, 826-835 (1993).
71. D. A. Geller, A. K. Nussler, M. Di Silvio, C. J. Lowenstein, R. A. Shapiro, S. C. Wang, R. L. Simmons et al., Cytokines endotoxine, and glucocorticoids regulate the expression of inducible nitric oxide synthase in hepatocytes. Proc. Natl. Acad. Sci. USA 90, 522-525 (1993).
72. C. A. Dinarello, Interleukin-1 and interleukin-1 antagonist. Blood 77, 1627-1652 (1991).
73. M. Frater Schoeder, W. Risau, R. Hallmann, P. Gautschi and P. Bohen, Tumor necrosis factor type alpha, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo. Proc. Natl. Acad. Sci. USA 84, 5277-5281 (1987).
74. L. J. Old, Tumor necrosis factor (TNF). Science 230, 630-632 (1985).
75. J. B. Hibbs Jr, C. Westenfelder, R. Taintor, Z. Vavrin, C. Kablitz, R. L. Baranowski, J. H. Waard, R. L. Menlove, M. P. McMurry and J. P. Kushner, Evidence for cytokine-inducible nitric oxide synthesis from L-arginine in patients receiving interleukin-2 therapy. J. Clin. Invest. 89, 867-877 (1992).
76. G-Methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: implications for the involvement of nitric oxide. Proc. Natl. Acad. Sci. USA 87, 3629-3632 (1990).
77. E. P. Sampaio, E. N. Sarno, R. Galilly, Z. A. Cohn and G. Kaplan, Thalidomide selectively inhibits tumor necrosis factor-alpha production by stimulated human monocytes. J. Exp. Med. 173, 699-703 (1991).
78. A. L. Moreira, E. P. Sampaio, A. Zmuidzinas, P. Frindt, K. A. Smith and G. Kaplan, Thalidomide exerts its inhibitory action on tumor necrosis factor-alpha by enhancing mRNA degradation. J. Exp. Med. 177, 1675-1680 (1993).
79. kB. Proc. Natl. Acad. Sci. USA 93, 3308-3312 (1996).
80. kB/Rel in induction of nitric oxide synthase. J. Biol. Chem. 269, 4705-4708 (1994).